VEGFA and endothelial dysfunction: Within the circulation, sFlt-1 binds free vascular endothelial growth factor and free placental growth factor, preventing their binding to the normal Flt-1 receptor (membrane bound), thereby antagonising their positive effects on the maternal endothelium[9] and resulting in widespread endothelial dysfunction.